Article Text

Download PDFPDF
Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding This work was supported by an unrestricted educational grant from Abbott pharmaceutical company.

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.